+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

OS2.6Identification of IDH1R132H-specific T cell receptors from a humanized mouse model and from glioma patients treated with an IDH1R132H-specific peptide vaccine



OS2.6Identification of IDH1R132H-specific T cell receptors from a humanized mouse model and from glioma patients treated with an IDH1R132H-specific peptide vaccine



Neuro-Oncology 18(Suppl_4): Iv5-Iv6




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 064888424

Download citation: RISBibTeXText

DOI: 10.1093/neuonc/now188.016


Related references

Os09.9 Identification of Idh1R132H-specific T cell receptors from glioma patients and from Mhc-humanized mice. Neuro-Oncology 19(Suppl_3): iii20, 2017

Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma. Proceedings of the National Academy of Sciences of the United States of America 111(39): 14217-14222, 2014

O4.08 * Agi5198, An Inhibitor Of Idh1R132H, Protects Idh1R132H Hct116 Cells Against Irradiation. Neuro-Oncology 16(Suppl 2): ii8-ii9, 2014

Mutant Idh1R132H bears a mutation-specific Cd4 T cell epitope suitable for vaccination of human Cns tumors. Journal of Neuroimmunology 275(1-2): 39, 2014

P09.04Adoptive T cell therapy for Idh1R132H-mutated low-grade glioma. Neuro-Oncology 18(Suppl_4): iv60, 2016

Anti-metastatic effect of the TM4SF5-specific peptide vaccine and humanized monoclonal antibody on colon cancer in a mouse lung metastasis model. Oncotarget 7(48): 79170-79186, 2016

IDH1R¹³²H decreases the proliferation of U87 glioma cells through upregulation of microRNA-128a. Molecular Medicine Reports 12(5): 6695-6701, 2015

Spontaneous in vitro senescence of glioma cells confirmed by an antibody against IDH1R132H. Anticancer Research 34(6): 2859-2867, 2014

A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation. Biochemical and Biophysical Research Communications 390(3): 547-551, 2009

NOG-hIL-4-Tg, a new humanized mouse model for producing tumor antigen-specific IgG antibody by peptide vaccination. Plos one 12(6): E0179239, 2017

Csig-40. Heterozygous Idh1R132H/Wt Created By Single Base Editing Inhibits Human Astroglial Cell Growth And Promotes Cell Migration. Neuro-Oncology 20(Suppl_6): vi52, 2018

Expression of Idh1 R132H in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis. Cancer Cell 30(4): 578-594, 2016

Os1.2Effects of the Idh1R132H mutation on redox-status and metabolism are cell type dependent but independent from D-2-hydroxyglutarate accumulation. Neuro-Oncology 18(Suppl_4): iv2, 2016

Results of a Phase 1/2 Study in Metastatic Renal Cell Carcinoma Patients Treated with a Patient-specific Adjuvant Multi-peptide Vaccine after Resection of Metastases. European Urology Focus 5(4): 604-607, 2019

Therapeutic effect of a TM4SF5-specific peptide vaccine against colon cancer in a mouse model. Bmb Reports 47(4): 215-220, 2014